By
JULIE CRESWELL
Published:
February 22, 2006
For
the influential class-action lawyer William S. Lerach, the news that arrived
late last Friday was a step closer to vindication.
James
Estrin/The New York Times
William
S. Lerach looks through shredded documents in the Enron case.
Dominating the Competition
Melvyn
I. Weiss, right, with David G. Bershad, left, and Steven G.
Schulman.
Mr. Lerach and a former partner, Melvyn I. Weiss,
were informed by government investigators that no charges would be filed
against them for now in a five-year-old inquiry into allegations that the two
used illegal tactics in shareholder lawsuits, lawyers involved in the case said
yesterday.
That
was welcome relief for the two lawyers. But Mr. Lerach, Mr. Weiss and the law
firm they once ran together remain under investigation, people close to the
case say.
"I
was informed by the government on Friday that Mel Weiss will not be included in
any indictment that the government may seek to bring at this time," said
Benjamin Brafman, a criminal defense lawyer
representing Mr. Weiss. A call to Mr. Lerach's lawyer, John W. Keker, was not returned, but people close to the
investigation said that Mr. Lerach received a similar message.
Instead,
it appears that the government will probably indict David G. Bershad and Steven
G. Schulman, two partners at the
And
the government could still indict Milberg Weiss itself, lawyers involved in the
case said. That could put the firm out of business, send its casework into
disarray, and land its 120 lawyers on the street. The lawyer representing the
law firm, William W. Taylor III of Zuckerman Spaeder
in
Richard
Robinson, the
To
those close to the case, the indications that prosecutors may be focusing on
Mr. Schulman and Mr. Bershad suggest that they continue to have a hard time
building a case against the two individuals who have always been the prime
targets of the investigation: Mr. Lerach and Mr. Weiss.
Brash
and hard charging, Mr. Lerach, who is based in
Mr.
Lerach has led attacks on many high-profile corporations, including AOL Time Warner, Dynegy, Qwest and WorldCom, often getting big settlements for investors who
accused executives and their financial advisers of misleading stockholders in
ways that cost them billions of dollars.
As
lead counsel in the shareholder lawsuit against Enron, Mr. Lerach has already
brokered record settlements with several Wall Street banks and brokers,
including Citigroup and J. P. Morgan, totaling more than $7.1 billion. Another
seven banks and brokerage firms named in the lawsuit are still fighting the
accusations.
Mr.
Lerach's prominence in securities litigation has led some people close to his
camp to suggest that the
Mr.
Lerach is a generous contributor to Democratic politicians and last year his
firm sued Halliburton, contending that the company defrauded
investors by manipulating and falsifying its financial statements from 1998 to
2001. During most of that period, Vice President Dick Cheney was Halliburton's
chief executive.
"The
whole issue of referral fees is absolutely, clearly legal," said Edward W.
Hayes, the lawyer representing Mr. Schulman. "I will not comment on
whether there is a political motivation, but it's clear that the Bush
administration and the California Republican Party hate class-action
lawyers."
Lawyers
involved in the case say that prosecutors hope that Mr. Schulman and Mr.
Bershad, if they are indicted, will yield to pressure to provide evidence
against Mr. Lerach and Mr. Weiss. But it is not clear whether they have any
proof that their partners committed any wrongdoing.
When
reached by telephone, Mr. Lerach would not comment on the investigation. Mr.
Weiss did not return a call to his office.
Calls
to Mr. Bershad's office and his lawyer were not
returned Tuesday.
In
building their case against Mr. Schulman and Mr. Bershad, prosecutors appear to
be relying heavily on information and testimony provided by Robert P. Sugarman, a former Milberg Weiss partner, Mr. Hayes said.
"There
are individuals with a strong personal and financial motive to make false
accusations against Steve Schulman," he said. "Sugarman
was internally a competitor with Steve Schulman and he lost out on the internal
competition."
"Sugarman had numerous personal problems with other members
of the firm," Mr. Hayes said. "He left the firm and there are other
very significant issues with him about which I am not prepared to comment on at
this time."
Mr.
Sugarman's lawyer,
Before its split in 2004, Milberg Weiss Bershad Hynes & Lerach was the
dominant player in the class-action lawsuit arena. Avidly scanning for sharp
drops in stock prices or strange announcements by companies, the firm's lawyers
would often race to the courthouse with a plaintiff in tow to be among the
first to file a lawsuit, hoping to grab the lead-plaintiff position.
Over the years, the firm pulled in billions of dollars in recoveries for
shareholders by suing corporations for defrauding investors.
"When the two firms were together they were clearly the dominant law
firm in the class-action securities-fraud litigation arena," said Joseph
A. Grundfest of
The firm was so powerful that Congress enacted laws aimed at reducing the
prominence of the firm and its star principals. In 1995, lawmakers approved the
Private Securities Litigation Reform Act, which, among its provisions, required
that large shareholders take over as lead plaintiffs in most suits. The
thinking behind the law was that large institutional shareholders like state
pension funds would not file frivolous suits.
Still, despite the legislation and the split, the two plaintiffs firms
remained dominant in the field in 2005. Last year, they were responsible for 57
percent of the lawsuits settled, up from 52 percent in 2004 when they operated
under one roof, according to data compiled by Cornerstone Research.
The firms associated with Mr. Lerach have made a very good living from the
fees they reaped in their shareholder lawsuits. (As of last fall, for example,
Mr. Lerach's firm had earned more than $680 million from the Enron case alone,
according to a new book "The Money Lawyers.")
The investigation into Mr. Lerach's and Mr. Weiss's practices was begun
more than five years ago after an ophthalmologist, Dr. Steven G. Cooperman, was
convicted on art-fraud charges. A frequent plaintiff in shareholder lawsuits
filed over the years by Milberg Weiss, Dr. Cooperman offered to provide
evidence to prosecutors against Milberg Weiss in hopes of receiving a reduced
sentence. A call to Dr. Cooperman's lawyer was not returned.
The investigation, though, seemed to cool off until last summer when the
In their indictment in June against Mr. Lazar, prosecutors charged him
with accepting "$2.4 million in secret and illegal kickback payments"
from a